Copyright
©The Author(s) 2016.
World J Gastroenterol. Sep 14, 2016; 22(34): 7625-7644
Published online Sep 14, 2016. doi: 10.3748/wjg.v22.i34.7625
Published online Sep 14, 2016. doi: 10.3748/wjg.v22.i34.7625
Table 5 Vaccination in special populations of inflammatory bowel disease patients
Pregnancy | ||
Category B | Category C | Category X |
Influenza (LAIV) | PPSV 23 | Varicella, if non-immune |
1 dose upon completion or termination of pregnancy and before discharge from health care facility. | ||
2nd dose 4-8 wk later. | ||
Influenza (IIV) | Zoster | |
Boostrix (Tdap) | Adacel (Tdap) | |
1 dose of Tdap vaccine during each pregnancy regardless of immunization status | 1 dose of Tdap vaccine during each pregnancy regardless of immunization status | |
HPV 4, HPV 2 | Meningococcus | |
PCV 13 | Hepatitis A and B vaccine | |
MMR, if non-immune | ||
1 dose upon completion or termination of pregnancy and before discharge from health care facility. | ||
2nd dose 4-8 wk later. | ||
The IBD traveler | ||
Vaccine | Type | Travel related indication |
Yellow fever | Live | Parts of South America and sub-Saharan Africa |
Typhoid | Live and Inactivated | Asia, Africa, Central and South America, The Caribbean, Oceania |
Polio | Live | |
Influenza | Inactivated | |
BCG vaccine | Live | Travel to highly endemic area > 1 yr |
Hepatitis A | Inactivated | Central or South America, Mexico, Asia( except Japan), Africa, Eastern Europe |
Meningococcal vaccine | Inactivated | sub-Saharan Africa, Saudi Arabia (during Hajj and Umrah pilgrimage) |
Japanese encephalitis virus | Inactivated | Rural Japan |
- Citation: Abegunde AT, Muhammad BH, Ali T. Preventive health measures in inflammatory bowel disease. World J Gastroenterol 2016; 22(34): 7625-7644
- URL: https://www.wjgnet.com/1007-9327/full/v22/i34/7625.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i34.7625